Please provide your email address to receive an email when new articles are posted on . Having a chronic respiratory infection in addition to bronchiectasis heightened the risk for an exacerbation and ...

Bronchiectasis is a condition where the bronchial tubes of your lungs are permanently damaged, widened, and thickened. These damaged air passages allow bacteria and mucus to build up and pool in your ...

BRONCHIECTASIS is protean in its expressions as it is sometimes obscure in its origin. The clinical picture varies in individual patients, but common to the severer cases is a history of harassing, ...

Highly symptomatic bronchiectasis patients have increased exacerbation risks, regardless of previous exacerbation history or disease severity. Current guidelines do not recommend preventive treatments ...

Bronchiectasis is a lung condition that causes a persistent cough and excess phlegm, or sputum. It is a permanent condition that gets worse over time. It can be fatal. The bronchi dilate, usually ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. HSK31858 given as 20 mg or 40 mg performed better than ...

We found no new evidence that affects the recommendations. For more information, see the surveillance decision. This guideline updates and replaces NICE evidence summaries ESUOM25, ESUOM38 and ES12.

The ASPEN randomized trial showed that novel brensocatib cut the annualized rate of pulmonary exacerbations by around 20% compared with placebo. Brensocatib is a DPP-1 inhibitor that works by reducing ...

A new study from researchers in Spain says that bronchiectasis is independently associated with an increased mortality risk in patients with moderate-to-severe COPD. Bronchiectasis, a permanent and ...